Definium Therapeutics, Inc. Foreign Currency Transaction Gain (Loss), Unrealized
Definium Therapeutics, Inc. (DFTX) reported Foreign Currency Transaction Gain (Loss), Unrealized of $11.00 thousand for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Cash Flow › Operating Activities
us-gaap:ForeignCurrencyTransactionGainLossUnrealized · last filed 2026-08-06
- Definium Therapeutics, Inc. foreign currency transaction gain (loss), unrealized for the quarter ending 2025-12-31 was $0.00, a 100.00% decline year-over-year.
- Definium Therapeutics, Inc. foreign currency transaction gain (loss), unrealized for the quarter ending 2025-09-30 was $1.00K, a 0.00% change year-over-year.
- Definium Therapeutics, Inc. foreign currency transaction gain (loss), unrealized for the quarter ending 2025-06-30 was -$1.00K, a 125.00% decline year-over-year.
- Definium Therapeutics, Inc. foreign currency transaction gain (loss), unrealized for the quarter ending 2025-03-31 was $0.00.
- Definium Therapeutics, Inc. foreign currency transaction gain (loss), unrealized for fiscal 2025 was $0.00.
- Definium Therapeutics, Inc. foreign currency transaction gain (loss), unrealized for fiscal 2024 was -$506.00K, a 239.39% decline from fiscal 2023.
- Definium Therapeutics, Inc. foreign currency transaction gain (loss), unrealized for fiscal 2023 was $363.00K, a 145.27% increase from fiscal 2022.
- Definium Therapeutics, Inc. foreign currency transaction gain (loss), unrealized for fiscal 2022 was $148.00K.
| Period end | Foreign Currency Transaction Gain (Loss), Unrealized 3 month | Foreign Currency Transaction Gain (Loss), Unrealized 6 month | Foreign Currency Transaction Gain (Loss), Unrealized 9 month | Foreign Currency Transaction Gain (Loss), Unrealized 12 month |
|---|---|---|---|---|
| 2026-06-30 | $11.00K 10-Q · filed 2026-08-06 | |||
| 2025-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $1.00K derived: sum of 2 quarters · filed 2026-02-26 | $0.00 derived: sum of 3 quarters · filed 2026-08-06 | $0.00 10-K · filed 2026-02-26 |
| 2025-09-30 | $1.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-06 | $0.00 derived: sum of 2 quarters · filed 2026-08-06 | $0.00 10-Q · filed 2025-11-06 | $3.00K derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-06-30 | -$1.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-06 | -$1.00K 10-Q · filed 2026-08-06 | $2.00K derived: sum of 3 quarters · filed 2026-08-06 | $3.00K derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-03-31 | $0.00 10-Q · filed 2025-05-08 | $3.00K derived: sum of 2 quarters · filed 2026-02-26 | $4.00K derived: sum of 3 quarters · filed 2026-02-26 | $8.00K derived: sum of 4 quarters · filed 2026-02-26 |
| 2024-12-31 | $3.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $4.00K derived: sum of 2 quarters · filed 2026-02-26 | $8.00K derived: sum of 3 quarters · filed 2026-02-26 | -$506.00K 10-K · filed 2026-02-26 |
| 2024-09-30 | $1.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-06 | $5.00K derived: sum of 2 quarters · filed 2025-11-06 | -$509.00K 10-Q · filed 2025-11-06 | -$146.00K derived: sum of 4 quarters · filed 2025-11-06 |
| 2024-06-30 | $4.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-07-31 | -$510.00K 10-Q · filed 2025-07-31 | -$147.00K derived: sum of 3 quarters · filed 2025-07-31 | -$484.00K derived: sum of 4 quarters · filed 2025-07-31 |
| 2024-03-31 | -$514.00K 10-Q · filed 2025-05-08 | -$151.00K derived: sum of 2 quarters · filed 2025-05-08 | -$488.00K derived: sum of 3 quarters · filed 2025-05-08 | |
| 2023-12-31 | $363.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-06 | $26.00K derived: sum of 2 quarters · filed 2025-03-06 | $363.00K 10-K · filed 2025-03-06 | |
| 2023-09-30 | -$337.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-07 | $0.00 10-Q · filed 2024-11-07 | ||
| 2023-06-30 | $337.00K 10-Q · filed 2024-08-13 | |||
| 2022-12-31 | $148.00K 10-K · filed 2024-02-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Cronos Group Inc. (CRON) | $1.223B | ||
| Tilray Brands, Inc. (TLRY) | United States | $0.554B | -5.97 |
| Canopy Growth Corp (CGC) | $0.395B | ||
| USANA HEALTH SCIENCES INC (USNA) | United States | $0.264B | -17.90 |
| Niagen Bioscience, Inc. (NAGE) | United States | $0.238B | 15.72 |
| FITLIFE BRANDS, INC. (FTLF) | United States | $0.087B | 16.59 |
| MANNATECH INC (MTEX) | United States | $0.014B | |
| NATURAL ALTERNATIVES INTERNATIONAL INC (NAII) | United States | $0.011B | -1.16 |
| Synergy CHC Corp. (SNYR) | United States | $0.001B | |
| Functional Brands Inc. (MEHA) | United States | $0.001B |